Abstract:Background: Sepsis-associated encephalopathy (SAE) is characterized by symptoms of delirium including hallucinations, impaired concentration, agitation, or coma and is associated with poor outcome in the early phase of sepsis. In addition, sepsis survivors often suffer from persisting memory deficits and impaired executive functions. Recent studies provide evidence that microglia are involved in the pathophysiology of SAE. Methods: Here, we investigated whether pharmacological depletion of microglia using PLX5622 (1200 ppm or 300 ppm) in the acute phase of sepsis is able to prevent long-term neurocognitive decline in a male mouse model of polymicrobial sepsis or lipopolysaccharide-induced sterile neuroinflammation. Therefore, we performed the novel object recognition test at different time points after sepsis to address hippocampus-dependent learning. To further assess synapse engulfment in microglia, colocalization analysis was performed using high-resolution 3D Airyscan imaging of Iba1 and Homer1. We also investigated the effect of PLX5622 on acute astrocyte and chronic microglia proliferation in the hippocampus after sepsis induction using immunofluorescence staining. Results: High-dose application of the colony stimulating factor 1 receptor (CSF1R) inhibitor PLX5622 (1200 ppm) seven days prior to sepsis induction lead to 70-80% microglia reduction but resulted in fatal outcome of bacterial sepsis or LPS induced inflammation. This is likely caused by severely compromised host immune response upon PLX5622-induced depletion of peripheral monocytes and macrophages. We therefore tested partial microglia depletion using a low-dose of PLX5622 (300 ppm) for seven days prior to sepsis which resulted in an increased survival in comparison to littermates subjected to high-dose CSF1R inhibiton and to a stable microglia reduction of ~ 40%. This partial microglia depletion in the acute stage of sepsis largely prevented the engulfment and microglia-induced stripping of postsynaptic terminals. In addition, PLX5622 low-dose microglia depletion attenuated acute astrogliosis as well as long-term microgliosis and prevented long-term neurocognitive decline after experimental sepsis. Conclusions: We conclude that partial microglia depletion before the induction of sepsis may be sufficient to attenuate long-term neurocognitive dysfunction. Application of PLX5622 (300 ppm) acts by reducing microglia-induced synaptic attachement/engulfment and preventing chronic microgliosis.

Trained Innate Immunity by Repeated Low-Dose Lipopolysaccharide Injections Displays Long-Term Neuroprotective Effects

Lipopolysaccharide Causes Persistent Cognitive Dysfunction In Mice With Activation Of Hmgb-1 And Inhibition Of Autophagy

Consecutive Injection of High-Dose Lipopolysaccharide Modulates Microglia Polarization via TREM2 to Alter Status of Septic Mice

Repetitive Administration of Low-Dose Lipopolysaccharide Improves Repeated Social Defeat Stress-Induced Behavioral Abnormalities and Aberrant Immune Response

Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice

Short-term memory impairment following recovery from systemic inflammation induced by lipopolysaccharide in mice

The Immune System Drives Synapse Loss During Lipopolysaccharide-Induced Learning and Memory Impairment in Mice

Environmental Conditions Differentially Affect Neurobehavioral Outcomes in a Mouse Model of Sepsis-Associated Encephalopathy.

Lactobacillus rhamnosus GG improves cognitive impairments in mice with sepsis

Low-dose PLX5622 treatment prevents neuroinflammatory and neurocognitive sequelae after sepsis

Dysfunction of NRG1/ErbB4 Signaling in the Hippocampus Might Mediate Long-term Memory Decline After Systemic Inflammation

Individual Differences in the Brain Are Associated with Resilience Versus Susceptibility to Lipopolysaccharide-Induced Memory Impairment

Reduced inhibition underlies early life LPS exposure induced-cognitive impairment: Prevention by environmental enrichment

Sepsis-Induced Selective Loss Of Nmda Receptors Modulates Hippocampal Neuropathology In Surviving Septic Mice

Early-life Exposure to Lipopolysaccharide Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Adulthood and Correlated with Increased Urine Corticosterone and Apoptotic CD4+ T Cells

Injection of Anti-proBDNF Attenuates Hippocampal-Dependent Learning and Memory Dysfunction in Mice With Sepsis-Associated Encephalopathy

Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairment

Model of neuroinflammation associated with cognitive dysfunction established by intraperitoneal injection of LPS

Lipopolysaccharide induces paired immunoglobulin-like receptor B (PirB) expression, synaptic alteration, and learning-memory deficit in rats

Minocycline Mitigated Enduring Neurological Consequences in the Mice Model of Sepsis

Experimentally Induced Sepsis Causes Extensive Hypomyelination in the Prefrontal Cortex and Hippocampus in Neonatal Rats